NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

VRAX

Virax Biolabs Group Ltd

Jun 30 • 04:00PM ET

0.7917

Dollar change +0.0117
Percentage change 1.50	%

Healthcare • Biotechnology • United Kingdom • NASD

Peers: MRNA BNTX PFE JNJ NVAX VXRT INO SABR CERS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.37	Insider Own	6.63%	Shs Outstand	4.34M	Perf Week	4.16%
Market Cap	3.44M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.05M	Perf Month	-17.36%
Enterprise Value	-3.48M	PEG	-	EPS next Q	-0.34	Inst Own	6.71%	Short Float	0.51%	Perf Quarter	-31.75%
Income	-6.58M	P/S	42.95	EPS this Y	31.76%	Inst Trans	-0.61%	Short Ratio	0.15	Perf Half Y	-53.97%
Sales	0.08M	P/B	0.24	EPS next Y	-	ROA	-79.92%	Short Interest	0.02M	Perf YTD	-64.81%
Book/sh	3.36	P/C	0.47	EPS next 5Y	-	ROE	-87.87%	52W High	9.00 -91.20%	Perf Year	-35.63%
Cash/sh	1.68	P/FCF	-	EPS past 3/5Y	-80.33% -52.25%	ROIC	-73.30%	52W Low	0.75 5.49%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	8.10% 11.87%	Gross Margin	-247.40%	Volatility	11.25% 7.96%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-43.55	EPS Y/Y TTM	43.76%	Oper. Margin	-7397.95%	ATR (14)	0.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.40	Sales Y/Y TTM	7.03%	Profit Margin	-7753.22%	RSI (14)	35.52	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.58	EPS Q/Q	45.81%	SMA20	-10.41%	Beta	1.65	Target Price	3.00
Payout	-	Debt/Eq	0.07	Sales Q/Q	-93.53%	SMA50	-18.40%	Rel Volume	0.67	Prev Close	0.78
Employees	17	LT Debt/Eq	0.04	Earnings	-	SMA200	-50.87%	Avg Volume	135.70K	Price	0.79
IPO	Jul 21, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	-37.84% -100.00%	Trades		Volume	91,127	Change	1.50%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-31-25	Initiated	H.C. Wainwright	Buy	$3

Mar-31-25 02:57PM	Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating (Benzinga)
Mar-18-25 07:30AM	Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes (PR Newswire)
Mar-13-25 07:30AM	Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting (PR Newswire) -12.35%
Mar-05-25 07:30AM	Virax Biolabs to Present at 19th World Immune Regulation Meeting (PR Newswire) -7.48%
Feb-25-25 07:00AM	Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy (PR Newswire)
06:45AM	Loading…
06:45AM	EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency (Benzinga)
Jan-14-25 09:41AM	Cosmos Health secures exclusive distribution agreement with Virax Biolabs (TipRanks)
Jan-13-25 09:20AM	Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries (ACCESSWIRE)
Dec-17-24 07:30AM	Virax Biolabs' CEO James Foster Issues Letter to Shareholders (PR Newswire) +10.39%
Dec-10-24 07:30AM	Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland (PR Newswire)
Oct-23-24 07:30AM	Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland (PR Newswire) +50.00%
07:15AM	EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland (Benzinga)
Sep-16-24 08:30AM	Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. (PR Newswire) +9.65%
08:30AM	Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar (ACCESSWIRE)
Sep-09-24 08:00AM	Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference (PR Newswire) -9.12%
09:03AM	Loading…
Aug-29-24 09:03AM	Virax Biolabs to Participate at 7th European Congress of Immunology (PR Newswire)
Aug-28-24 07:30AM	Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East (PR Newswire)
07:16AM	EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East (Benzinga)
Aug-23-24 04:09PM	Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares (PR Newswire) +5.21% -15.41%
Aug-21-24 09:30PM	Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares (PR Newswire) +79.78% -19.06%
10:20AM	Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits (ACCESSWIRE)
Jun-07-24 08:31AM	Why Is Virax Biolabs (VRAX) Stock Down 15% Today? (InvestorPlace)
07:22AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-06-24 07:55AM	Why Is Virax Biolabs (VRAX) Stock Up 115% Today? (InvestorPlace) +84.11%
07:38AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Apr-25-24 09:45AM	EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes (Benzinga) +5.49%
08:00AM	Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 (PR Newswire)
Apr-16-24 07:30AM	Virax Biolabs to Participate at ESCMID Global 2024 (PR Newswire)
Mar-15-24 04:30PM	Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency (PR Newswire)
Dec-21-23 07:30AM	Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients (PR Newswire) -14.63%
07:30AM	Loading…
Dec-18-23 07:30AM	Virax Biolabs' CEO James Foster Issues Letter to Shareholders (PR Newswire) -11.84%
Dec-14-23 07:30AM	Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation (PR Newswire)
Sep-21-23 12:21PM	VRAX: Virax Biolabs transformative preventive diagnostic platform supports higher stock price. (Zacks)
Sep-12-23 07:30AM	Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar (PR Newswire)
Sep-01-23 07:30AM	Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum (PR Newswire)
Aug-03-23 07:30AM	Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid (PR Newswire)
Jul-18-23 07:30AM	Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities (PR Newswire)
Jun-21-23 12:14PM	VRAX: Virax Biolabs releases shareholder letter and financial results for the fiscal year ending March 31, 2023. (Zacks Small Cap Research)
Jun-14-23 07:30AM	Virax Biolabs' CEO James Foster Issues Letter to Shareholders (PR Newswire) +24.16%
May-05-23 08:19AM	VRAX: UPDATE: Innovative biotechnology company developing a potentially groundbreaking immunology platform based around proprietary T-Cell testing technology. (Zacks Small Cap Research)
May-04-23 07:30AM	Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park (PR Newswire) -8.58%
Apr-19-23 07:30AM	Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits (PR Newswire) -7.21%
Mar-10-23 05:17PM	Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules (PR Newswire) -5.43% -6.77%
Mar-08-23 08:55AM	Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules (PR Newswire) -11.57%
Mar-07-23 09:15AM	EXCLUSIVE: Virax Biolabs Starts Distribution Of Avian Flu Test Kits In Europe (Benzinga) +82.53%
07:30AM	Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit (PR Newswire)
Feb-16-23 07:12AM	VRAX: INITIATION: Innovative biotechnology company developing a potentially groundbreaking immunology platform based around proprietary T-Cell testing technology (Zacks Small Cap Research)
Feb-07-23 10:07AM	New York City scraps COVID vaccine mandate for public-sector workers. This is the right moment for this decision, Mayor Adams says. (MarketWatch) +6.16%
08:30AM	Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM) (PR Newswire)
Feb-06-23 04:05PM	Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference (PR Newswire)
Feb-02-23 07:30AM	Virax Biolabs' CEO James Foster Issues Letter to Shareholders (PR Newswire) +6.89%
Jan-04-23 07:30AM	Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit (PR Newswire) +7.07%
07:00AM	EXCLUSIVE: Virax Biolabs Introduces Human Papillomavirus Test Kit In European Union (Benzinga)
Dec-13-22 03:52PM	10 Biotech Stocks With The Biggest Upside (Insider Monkey) -8.40%
Dec-06-22 07:30AM	COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States (PR Newswire) -5.11%
Nov-15-22 07:30AM	Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales (PR Newswire)
Nov-08-22 04:30PM	Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement (PR Newswire) -12.50% -6.80%
Nov-04-22 07:30AM	Virax Biolabs Group Limited Announces $3.8 Million Private Placement (PR Newswire) -27.51%
Nov-03-22 11:02AM	Weekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion (MarketWatch) +36.31%
07:30AM	Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit (PR Newswire)
07:10AM	EXCLUSIVE: Virax Biolabs Launches RSV/Flu/COVID-19 Combo Rapid Test Kit In Europe (Benzinga)
Oct-26-22 07:30AM	Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study (PR Newswire)
Sep-22-22 07:30AM	Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc. (PR Newswire) +7.89%
Sep-20-22 07:30AM	Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit (PR Newswire) +41.30%
07:15AM	EXCLUSIVE: Newly Listed Virax Biolabs Launches Monkeypox Antigen Rapid Test (Benzinga)
Sep-12-22 09:17AM	10 Best Penny Stocks to Buy in September (Insider Monkey)
07:00AM	Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference (PR Newswire)
Sep-06-22 04:00PM	Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY (PR Newswire) -10.61%
Aug-16-22 07:30AM	Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering (PR Newswire) -7.70%
Jul-29-22 06:40PM	Why Virax Biolabs Stock Plummeted 74% On Friday (Motley Fool) -74.04% +119.44%
Jul-26-22 08:00AM	Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit (GlobeNewswire) +9.76%
Jul-21-22 10:33AM	Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX (GlobeNewswire)

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VRAX

Virax Biolabs Group Ltd

Upgrade your FINVIZ experience